Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies

INTRODUCTION: With more than 150 million chronically infected people, hepatitis C virus (HCV) remains a substantial global health burden. Direct-acting antivirals have dramatically improved viral cure. However, limited access to therapy, late stage detection of infection and re-infection following c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Expert Rev Vaccines
Autors principals: Fauvelle, Catherine, Colpitts, Che C., Keck, Zhen-yong, Pierce, Brian G., Foung, Steven K.H., Baumert, Thomas F.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156833/
https://ncbi.nlm.nih.gov/pubmed/27267297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2016.1194759
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars